MANNITOL 20% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Mannitol 20% In Plastic Container patents expire, and what generic alternatives are available?
Mannitol 20% In Plastic Container is a drug marketed by B Braun and Icu Medical Inc and is included in two NDAs.
The generic ingredient in MANNITOL 20% IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the mannitol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MANNITOL 20% IN PLASTIC CONTAINER?
- What are the global sales for MANNITOL 20% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for MANNITOL 20% IN PLASTIC CONTAINER?
Summary for MANNITOL 20% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 164 |
| Clinical Trials: | 225 |
| DailyMed Link: | MANNITOL 20% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for MANNITOL 20% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Geneva | Phase 3 |
| Morten Hostrup, PhD | N/A |
| University Hospital Inselspital, Berne | Early Phase 1 |
Pharmacology for MANNITOL 20% IN PLASTIC CONTAINER
| Drug Class | Osmotic Diuretic |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for MANNITOL 20% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | MANNITOL 20% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 020006-004 | Jul 26, 1993 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Icu Medical Inc | MANNITOL 20% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 019603-004 | Jan 8, 1990 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for MANNITOL 20% IN PLASTIC CONTAINER
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Pharmaxis Europe Limited | Bronchitol | mannitol | EMEA/H/C/001252 Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care. |
Authorised | no | no | no | 2012-04-13 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
